arrow_back Trending Legislation
Share share

Designating July 15 as National Leiomyosarcoma Awareness Day

The Senate supports designating July 15, 2024, as National Leiomyosarcoma Awareness Day to raise public awareness about this rare and aggressive cancer. This resolution acknowledges the challenges faced by patients, including resistance to standard treatments. Increased awareness is crucial for early diagnosis and better support for affected individuals and their families.
Key points
Official recognition of July 15th to increase public knowledge about leiomyosarcoma, a rare and difficult-to-treat cancer.
Highlighting that survival rates for this cancer have not significantly improved in the last 30 years.
Commending the efforts of organizations and individuals dedicated to improving patient quality of life and supporting research.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
A resolution expressing support for the designation of July 15, 2024, as "National Leiomyosarcoma Awareness Day".
Print number: SRES 775
Sponsor: Sen. Stabenow, Debbie [D-MI]
Process start date: 2024-07-30
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Designating July 15 as National Leiomyosarcoma Awareness Day

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is SRES 775.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2024-07-30.

What are the main provisions?

Key points include:

  • Official recognition of July 15th to increase public knowledge about leiomyosarcoma, a rare and difficult-to-treat cancer.
  • Highlighting that survival rates for this cancer have not significantly improved in the last 30 years.
  • Commending the efforts of organizations and individuals dedicated to improving patient quality of life and supporting research.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Stabenow, Debbie [D-MI].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of SRES 775

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health